Krishna Institute of Medical Sciences Share Price

NSE
KIMS •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Krishna Institute of Medical Sciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
7.2
TTM PE Ratio
Above industry Median
71.5
Price to Book Ratio
High in industry
11.3
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-22.7

Krishna Institute of Medical Sciences Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Krishna Institute of Medical Sciences Ltd Quarterly Revenue

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
777.3 Cr
688.4 Cr
633.8 Cr
605.84 Cr
652.48 Cr

Krishna Institute of Medical Sciences Ltd Yearly Revenue

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
2511.2 Cr
2223.55 Cr
1671.08 Cr
1340.1 Cr
1128.73 Cr

Krishna Institute of Medical Sciences Ltd Quarterly Net Profit/Loss

Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
120.7 Cr
95.2 Cr
71.62 Cr
76.67 Cr
101.29 Cr

Krishna Institute of Medical Sciences Ltd Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
336.28 Cr
365.81 Cr
334.28 Cr
205.48 Cr
115.07 Cr

Krishna Institute of Medical Sciences Ltd shareholding Pattern

Promoter
38.8%
Foreign Institutions
15.8%
Mutual Funds
25.8%
Domestic Institutions
32.3%
Public
13%
Promoter
38.8%
Foreign Institutions
17.8%
Mutual Funds
25.3%
Domestic Institutions
32.2%
Public
11.2%
Promoter
38.8%
Foreign Institutions
16.7%
Mutual Funds
26.3%
Domestic Institutions
33.2%
Public
11.3%
Promoter
38.8%
Foreign Institutions
15.3%
Mutual Funds
27.4%
Domestic Institutions
34.2%
Public
11.7%
Promoter
38.8%
Foreign Institutions
14.2%
Mutual Funds
27%
Domestic Institutions
34.8%
Public
12.1%
Promoter
38.8%
Foreign Institutions
13.2%
Mutual Funds
27.4%
Domestic Institutions
35.7%
Public
12.2%

Krishna Institute of Medical Sciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
603.10
10Day EMA
603.20
12Day EMA
601.80
20Day EMA
594.30
26Day EMA
588.70
50Day EMA
568.90
100Day EMA
534.20
200Day EMA
488.50
5Day SMA
608.30
10Day SMA
608.90
20Day SMA
595.10
30Day SMA
582.00
50Day SMA
564.40
100Day SMA
528.80
150Day SMA
486.10
200Day SMA
467.30
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
786332 Rs
975665 Rs
Week Rs
484581 Rs
716723 Rs
Month Rs
384558 Rs
685732 Rs
Resistance & Support
592.47
Pivot
Resistance
First Resistance
596.73
Second Resistance
601.22
Third Resistance
605.48
Support
First Support
587.98
Second support
583.72
Third Support
579.23
Relative Strength Index
52.19
Money Flow Index
63.98
MACD
13.07
MACD Signal
14.99
Average True Range
19.02
Average Directional Index
42.49
Rate of Change (21)
6.80
Rate of Change (125)
47.58

Krishna Institute of Medical Sciences Ltd Company background

Founded in: 1973
Managing director: Bhaskara Rao Bollineni
Krishna Institute of Medical Sciences Limited (KIMS) was incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, name of the Company was changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004. Pursuant to the conversion of Company to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh Maharashtra providing multidisciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 2,120 beds, including 1,705 operational beds. The Hospitals are equipped with stateoftheart medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India (NABH). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) (AHPI) for nursing excellence, in 2015 and for Patient Friendly Hospital, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 20152016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, postgraduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 202223, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 202223, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022 SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.
Read More

Krishna Institute of Medical Sciences Ltd FAQs

Krishna Institute of Medical Sciences Ltd shares are currently priced at 592.25 on NSE and 592.75 on BSE as of 12/12/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Krishna Institute of Medical Sciences Ltd [KIMS] share was 55.08. The Krishna Institute of Medical Sciences Ltd [KIMS] share hit a 1-year low of Rs. 350 and a 1-year high of Rs. 634.65.

The market cap of Krishna Institute of Medical Sciences Ltd is Rs. 23698.23 Cr. as of 12/12/2024 12:00:00 AM.

The PE ratios of Krishna Institute of Medical Sciences Ltd is 99.12 as of 12/12/2024 12:00:00 AM.

The PB ratios of Krishna Institute of Medical Sciences Ltd is 11.87 as of 12/12/2024 12:00:00 AM

The Mutual Fund Shareholding was 25.77% at the end of 12/12/2024 12:00:00 AM.

You can easily buy Krishna Institute of Medical Sciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -